Form 4: Tenaya Therapeutics Director Receives Stock Option Grant
Statement of Changes in Beneficial Ownership
Director Deepak Srivastava was granted 120,000 stock options in Tenaya Therapeutics, Inc. as part of the company's equity incentive plan.
Summary
- Director Deepak Srivastava received a grant of 120,000 stock options on May 28, 2026.
- The options have an exercise price of $0.7989 per share.
- The options are set to vest in full on May 28, 2027, or the day before the next annual stockholders meeting, whichever is earlier.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which carries a neutral sentiment.
Positives
- Alignment of director interests with long-term shareholder value through equity-based compensation.
Negatives
- Potential future dilution of existing shareholders upon the exercise of these options.
Risks
- The value of the options is subject to the future market performance of Tenaya Therapeutics common stock.
Future Outlook
The options vest in one year, contingent upon the director's continued service to the company.
Industry Context
StockSavvy.ai notes that equity grants to directors are standard corporate governance practices in the biotechnology sector to ensure board members remain incentivized to oversee long-term strategic growth.
Comparison to Industry Standards
- The grant of stock options to non-employee directors is a common practice among small-cap biotech firms to attract and retain high-level scientific and industry expertise.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Compensation | Grant of stock options under the 2021 Equity Incentive Plan. | 05/28/2026 | Standard alignment of director compensation with company performance. |
Stakeholder Impact
- Shareholders may experience minor dilution if these options are exercised in the future.
Next Steps
- Vesting of options on May 28, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/28/2026 | Date of the stock option grant transaction. |
| 05/29/2026 | Date the Form 4 was filed with the SEC. |
| 05/28/2027 | Vesting date for the granted stock options. |
| 05/27/2036 | Expiration date for the granted stock options. |
Keywords
Tenaya Therapeutics, TNYA, Form 4, Insider Trading, Stock Options, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.